Compania de Minas Buenaventura SAA
NYSE:BVN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.2944
26.76
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Compania de Minas Buenaventura SAA
Research & Development
Compania de Minas Buenaventura SAA
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Compania de Minas Buenaventura SAA
NYSE:BVN
|
Research & Development
-$22.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
6%
|
|
|
M
|
Minera IRL Ltd
CNSX:MIRL
|
Research & Development
-$127k
|
CAGR 3-Years
34%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Compania de Minas Buenaventura SAA
Glance View
Compania de Minas Buenaventura SAA is a PE-based company operating in Metals & Mining industry. The company is headquartered in San Isidro, Lima. Compania de Minas Buenaventura SAA is a Peru-based company primarily engaged in the mining industry. The firm and its subsidiaries focus on the exploration, extraction, concentration, smelting, and commercialization of polymetallic minerals and metals. Their key product is monohydrate manganese sulphate, which is a mineral compound. The firm's segments include: Production and sale of minerals; Construction, development and exploration of projects; Generation and transmission of energy; Insurance brokerage; Leasing of mining concessions; Investments in shares; and Industrial activities. The firm operates the Orcopampa, Uchucchacua, Julcani, and Tambomayo mines. Additionally, the Company owns interests in various mines and operates hydroelectric power plants.
See Also
What is Compania de Minas Buenaventura SAA's Research & Development?
Research & Development
-22.4m
USD
Based on the financial report for Sep 30, 2025, Compania de Minas Buenaventura SAA's Research & Development amounts to -22.4m USD.
What is Compania de Minas Buenaventura SAA's Research & Development growth rate?
Research & Development CAGR 10Y
6%
Over the last year, the Research & Development growth was -4%. The average annual Research & Development growth rates for Compania de Minas Buenaventura SAA have been -14% over the past three years , -23% over the past five years , and 6% over the past ten years .